Active15713244Private limited companyLondon

SENTINAL4D LIMITED

Significant control: Professor Christopher James Bakal (25–50%), Matthew Richard De Vries (25–50%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Sentinal4d Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

SENTINAL4D LIMITED is an active private limited company (company number 15713244) incorporated on 10 May 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2025, showing net assets of £739k and cash of £567k, with 2 employees on average.

Peer position · net assets

By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).

Ownership and control

2 active

PC
Professor Christopher James Bakal
Individual · since 10 May 2024
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
MR
Mr Matthew Richard De Vries
Individual · since 10 May 2024
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 10 May 20242 yrs ago
Next accounts due: 28 February 2027in 128 days
Confirmation statement due: 24 May 2027in 213 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full
Size band: MicroCompanies Act thresholds

Financials

1 period on record · latest ending 31 May 2025

Net assets

£739k

1 period on record

Cash at bank

£567k

1 period on record

Turnover

Not reported

Employees

1 period on record

Filed accounts by period, newest first
Period end	Net assets	Cash	Debtors	Creditors <1y	Turnover	Profit	Employees
31 May 2025	£739k	£567k	£217k	—	—	—	2

Cash per employee£284kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Filing and accounts signals

Facts from the register · no rating

Net assets above zeroNet assets £739,126 at 31 May 2025
Cash at bank of £50,000 or moreCash £567,457
Incorporated two to five years agoIncorporated 10 May 2024

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

24 May 2027Confirmation statement duein 213 days
28 Feb 2027Next accounts duein 128 days
31 May 2025Accounts period endNet assets £739k · small accounts
10 May 2024Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 10 May 2024 · in May 2024.

Reminders for SENTINAL4D LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.